Practice pointer: Lithium and chronic kidney disease

BMJ (Online)

Volumn 339, Issue 7713, 2009, Pages 166-169

  Kripalani, Mukesh ^a   Shawcross, James ^b   Reilly, Joe ^c   Main, John ^b  

^a Woodside Resource Centre   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^c DURHAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; ANTIDEPRESSANT AGENT; LITHIUM DERIVATIVE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; KIDNEY BIOPSY; KIDNEY FUNCTION; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SCREENING; TUBULAR DYSFUNCTION; ARTICLE; BIPOLAR DISORDER; CHRONIC KIDNEY FAILURE; DIET THERAPY; DRUG EFFECT; DRUG INTERACTION; HUMAN; INCIDENTAL FINDING;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DRUG INTERACTIONS; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENTAL FINDINGS; KIDNEY FAILURE, CHRONIC; LITHIUM COMPOUNDS;

EID: 68249132772     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2452     Document Type: Review

References (12)

1. National Institute for Health and Clinical Excellence. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. 2006. (Clinical guideline 38.) www.nice.org.uk/Guidance/CG38
2. National Institute for Health and Clinical Excellence. Early identification and management of chronic kidney disease in adults in primary and secondary care. 2008. (Clinical guideline 73.) www.nice.org.uk/Guidance/CG73
3. Morriss R, Benjamin B. Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease. Br J Psychiatry 2008;193:93-5.[Abstract/Free Full Text]
4. Gitlin M. Lithium and the kidney: an updated review. Drug Safety 1999;20:231-43.[CrossRef][Web of Science][Medline]
5. Schreiner A, Waldherr R, Rohmeiss P, Hewer W. Focal segmental glomerulosclerosis and lithium treatment. Am J Psychiatry 2000;157:834.[Free Full Text]
6. Lepkifker E, Sverdlik A, Iancu I, Ziv R, Segev S, Kotler M. Renal insufficiency in long-term lithium treatment. J Clin Psychiatry 2004;65:850-6.[Web of Science][Medline]
7. Go AS, Chertow GM, Fan D. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalisation. N Engl J Med 2004;351:1296-305.[Abstract/Free Full Text]
8. Oakley PW, Whyte IM, Carter GL. Lithium toxicity: an iatrogenic problem in susceptible individuals. Aust NZ J Psychiat 2001;35:833-40.[CrossRef]
9. Waring WS. Management of lithium toxicity. Toxicol Rev 2006;25:221-30.[CrossRef][Medline]
10. Lehmann K, Ritz E. Angiotensin-converting enzyme inhibitors may cause renal dysfunction in patients on long-term lithium treatment. Am J Kidney Dis 1995;25:82-7.[CrossRef][Web of Science][Medline]
11. Rosa AR, Marco M, Fachel JM, Kapczinski F, Stein AT, Barros HM. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:217-24.[CrossRef][Medline]
12. NHS Information Centre. 2007-2008. Coronary heart disease. Quality Outcomes Framework summary tables. www.ic.nhs.uk/webfiles/QOF/2007-08/ NewFilesGS/National%20QOF%20tables%202007-08%20-%20clinical.xls